{"id":3908,"date":"2025-01-08T18:09:06","date_gmt":"2025-01-08T12:39:06","guid":{"rendered":"https:\/\/indianlawsociety.com\/?p=3908"},"modified":"2025-01-13T18:38:02","modified_gmt":"2025-01-13T13:08:02","slug":"production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance","status":"publish","type":"post","link":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/","title":{"rendered":"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance"},"content":{"rendered":"<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The Indian government&#8217;s Production Linked Incentive (PLI) scheme for pharmaceuticals aims to promote domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs). This initiative is designed to reduce India&#8217;s reliance on imports and build a robust, self-sufficient pharmaceutical industry. This article will discuss the key features and objectives of the scheme.<\/span><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Background: Addressing Import Dependency<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The Indian pharmaceutical industry, while a global leader, relies heavily on imports for key raw materials, particularly bulk drugs, which account for a substantial portion of the country\u2019s pharmaceutical imports. The PLI scheme was launched to address this issue by incentivizing domestic production of crucial inputs.<\/span><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Objectives: Self-Reliance and Domestic Manufacturing<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The objectives of the PLI scheme are:<\/span><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">To achieve self-reliance in the production of critical KSMs, DIs, and APIs.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Reduce dependence on imports of key pharmaceutical materials.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Provide financial incentives based on committed investment and sales.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Increase domestic manufacturing capacity and encourage local production.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Key Components: Incentives Based on Performance<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The PLI scheme focuses on:<\/span><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Providing financial incentives based on committed investment and sales of eligible products.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Targeting key products across four segments &#8211; Fermentation based KSMs\/DIs, Niche Fermentation based KSMs\/DIs\/APIs, Chemical Synthesis based KSMs\/DIs, and other Chemical Synthesis based KSMs\/DIs\/APIs.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Encouraging both greenfield and brownfield projects for the establishment of eligible units.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Eligibility Criteria: Focusing on Qualified Applicants<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">Eligible applicants for the scheme are:<\/span><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Proprietary firms, partnership firms, Limited Liability Partnerships (LLP) or Companies registered in India proposing to manufacture eligible products.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Organizations making a committed investment in a greenfield project.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Entities demonstrating a net worth of at least 30% of the committed investment<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Organizations achieving a minimum of 70% to 90% Domestic Value Addition (DVA), depending on the manufacturing process.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Financial Incentives: Based on Performance<\/span><\/strong><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">The scheme provides incentives for a period ranging from FY 2023-24 to FY 2028-29. The duration of incentive varies across different categories of products (fermentation based products or chemically synthesized products).<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">The incentive rate for fermentation based products is 20% for the first four years, 15% for the fifth year and 5% for the sixth year. The incentive rate for chemical synthesis based products is 10% for six years.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Incentives are calculated based on net sales of eligible products and are subject to a pre-determined ceiling amount.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Project Implementation and Monitoring:<\/span><\/strong><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">A Project Management Agency (PMA) is appointed to oversee the implementation and verify compliance.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">The Empowered Committee (EC) makes final approval decisions.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">The scheme uses an online portal for submitting applications, tracking progress, and ensuring transparency.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">A Technical Committee (TC) provides expert opinions on technical issues related to the scheme.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Independent third-party evaluation will also be carried out to assess effectiveness.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Detailed Processes:<\/span><\/strong><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">The article explains several key steps:<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* The process for availing the incentives,<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* Eligibility criteria,<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* Calculation of incentives,<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* The process for applying,<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* The evaluation and approval process<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* Monitoring and evaluation methods<\/span><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">* Procurement guidelines<\/span><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Conclusion<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The Production Linked Incentive (PLI) scheme for pharmaceuticals is a critical initiative for India to achieve self-reliance and reduce import dependence in key areas of the pharmaceutical sector. By providing incentives linked to performance, the scheme encourages domestic manufacturing, fosters innovation and improves the quality and availability of essential drugs and raw materials.<\/span><\/p>\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/Production-Linked-Incentive-PLI-scheme-for-Pharmaceuticals.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of Production Linked Incentive (PLI) scheme for Pharmaceuticals.\"><\/object><a id=\"wp-block-file--media-758c2402-f9ce-416d-bb7a-260ee3aecde8\" href=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/Production-Linked-Incentive-PLI-scheme-for-Pharmaceuticals.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Production Linked Incentive (PLI) scheme for Pharmaceuticals<\/a><a href=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/Production-Linked-Incentive-PLI-scheme-for-Pharmaceuticals.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-758c2402-f9ce-416d-bb7a-260ee3aecde8\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"The Indian pharmaceutical industry, while a global leader, relies heavily on imports for key raw materials, particularly bulk drugs, which account for a substantial portion of the country\u2019s pharmaceutical imports. The PLI scheme was launched to address this issue by incentivizing domestic production of crucial inputs.","protected":false},"author":1,"featured_media":6057,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[358,25,49],"tags":[655,654,646,652,653,651,650],"class_list":{"0":"post-3908","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-chemicals-and-fertilizers","8":"category-law-library","9":"category-schemes-and-yojanas","10":"tag-api-manufacturing","11":"tag-drug-intermediates","12":"tag-indian-pharma","13":"tag-ksms","14":"tag-pharmaceutical-incentives","15":"tag-pli-scheme","16":"tag-production-linked-incentive-scheme","17":"cs-entry","18":"cs-video-wrap"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance\" \/>\n<meta property=\"og:description\" content=\"The Indian pharmaceutical industry, while a global leader, relies heavily on imports for key raw materials, particularly bulk drugs, which account for a substantial portion of the country\u2019s pharmaceutical imports. The PLI scheme was launched to address this issue by incentivizing domestic production of crucial inputs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/\" \/>\n<meta property=\"og:site_name\" content=\"Insights by Karma AI\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-08T12:39:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T13:08:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1224\" \/>\n\t<meta property=\"og:image:height\" content=\"816\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karma AI\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karma AI\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/\"},\"author\":{\"name\":\"Karma AI\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/person\\\/cfb78f37dfe74f0397dc673286495f01\"},\"headline\":\"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance\",\"datePublished\":\"2025-01-08T12:39:06+00:00\",\"dateModified\":\"2025-01-13T13:08:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/\"},\"wordCount\":549,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"keywords\":[\"API Manufacturing\",\"Drug Intermediates\",\"Indian Pharma\",\"KSMs\",\"Pharmaceutical Incentives\",\"PLI Scheme\",\"Production Linked Incentive Scheme\"],\"articleSection\":[\"Chemicals &amp; Fertilizers\",\"Law Library\",\"Schemes &amp; Yojanas\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/\",\"name\":\"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"datePublished\":\"2025-01-08T12:39:06+00:00\",\"dateModified\":\"2025-01-13T13:08:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"contentUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"width\":1224,\"height\":816},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/karma.law\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/\",\"name\":\"Insights by Karma AI\",\"description\":\"Law Simplified\",\"publisher\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#organization\"},\"alternateName\":\"Insights by Karma AI\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/karma.law\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#organization\",\"name\":\"Karma AI - Think Legal\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cropped-icon-1.png\",\"contentUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cropped-icon-1.png\",\"width\":512,\"height\":512,\"caption\":\"Karma AI - Think Legal\"},\"image\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/person\\\/cfb78f37dfe74f0397dc673286495f01\",\"name\":\"Karma AI\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g\",\"caption\":\"Karma AI\"},\"sameAs\":[\"https:\\\/\\\/karma.law\\\/insights\"],\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/","og_locale":"en_US","og_type":"article","og_title":"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance","og_description":"The Indian pharmaceutical industry, while a global leader, relies heavily on imports for key raw materials, particularly bulk drugs, which account for a substantial portion of the country\u2019s pharmaceutical imports. The PLI scheme was launched to address this issue by incentivizing domestic production of crucial inputs.","og_url":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/","og_site_name":"Insights by Karma AI","article_published_time":"2025-01-08T12:39:06+00:00","article_modified_time":"2025-01-13T13:08:02+00:00","og_image":[{"width":1224,"height":816,"url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","type":"image\/jpeg"}],"author":"Karma AI","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karma AI","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#article","isPartOf":{"@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/"},"author":{"name":"Karma AI","@id":"https:\/\/karma.law\/insights\/#\/schema\/person\/cfb78f37dfe74f0397dc673286495f01"},"headline":"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance","datePublished":"2025-01-08T12:39:06+00:00","dateModified":"2025-01-13T13:08:02+00:00","mainEntityOfPage":{"@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/"},"wordCount":549,"commentCount":0,"publisher":{"@id":"https:\/\/karma.law\/insights\/#organization"},"image":{"@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#primaryimage"},"thumbnailUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","keywords":["API Manufacturing","Drug Intermediates","Indian Pharma","KSMs","Pharmaceutical Incentives","PLI Scheme","Production Linked Incentive Scheme"],"articleSection":["Chemicals &amp; Fertilizers","Law Library","Schemes &amp; Yojanas"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/","url":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/","name":"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance","isPartOf":{"@id":"https:\/\/karma.law\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#primaryimage"},"image":{"@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#primaryimage"},"thumbnailUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","datePublished":"2025-01-08T12:39:06+00:00","dateModified":"2025-01-13T13:08:02+00:00","breadcrumb":{"@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#primaryimage","url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","contentUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","width":1224,"height":816},{"@type":"BreadcrumbList","@id":"https:\/\/karma.law\/insights\/law-library\/production-linked-incentive-pli-scheme-for-pharmaceuticals-fostering-self-reliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/karma.law\/insights\/"},{"@type":"ListItem","position":2,"name":"Production Linked Incentive (PLI) Scheme for Pharmaceuticals: Fostering Self-Reliance"}]},{"@type":"WebSite","@id":"https:\/\/karma.law\/insights\/#website","url":"https:\/\/karma.law\/insights\/","name":"Insights by Karma AI","description":"Law Simplified","publisher":{"@id":"https:\/\/karma.law\/insights\/#organization"},"alternateName":"Insights by Karma AI","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/karma.law\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/karma.law\/insights\/#organization","name":"Karma AI - Think Legal","url":"https:\/\/karma.law\/insights\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/karma.law\/insights\/#\/schema\/logo\/image\/","url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/cropped-icon-1.png","contentUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/cropped-icon-1.png","width":512,"height":512,"caption":"Karma AI - Think Legal"},"image":{"@id":"https:\/\/karma.law\/insights\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/karma.law\/insights\/#\/schema\/person\/cfb78f37dfe74f0397dc673286495f01","name":"Karma AI","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g","caption":"Karma AI"},"sameAs":["https:\/\/karma.law\/insights"],"url":"https:\/\/karma.law\/insights\/author\/admin\/"}]}},"jetpack_featured_media_url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","_links":{"self":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts\/3908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/comments?post=3908"}],"version-history":[{"count":1,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts\/3908\/revisions"}],"predecessor-version":[{"id":3913,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts\/3908\/revisions\/3913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/media\/6057"}],"wp:attachment":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/media?parent=3908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/categories?post=3908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/tags?post=3908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}